Summary
We have compared the kinetic growth patterns of To-336, MEQ11, KRT, and SK2 rubella vaccine strains licensed in Japan at 37° and 39° C with those of progenitor wild strains of rubella virus. The growth of vaccine strains was depressed at 39° C to a level about 3 log10 lower than that at 37° C. The difference in virus titer attained by wild strains at 37° and 39° C was less than tenfold. The growth potential at 39° C paralleled the immunogenic marker of rubella virus,i.e. the capability of virus to induce antibody response upon subcutaneous injection in rabbits for all wild and vaccine strains examined, including one strain at an intermediate level of attenuation. Several clones were isolated from the progeny produced by a vaccine strain during the growth at 39° C. Among them were partial revertants in immunogenic marker as well as in the growth potential at 39° C. It was concluded that the immunogenic marker of rubella virus in rabbits represented its capability to replicate at the body temperature of the animal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams, C. E.: The Rabbit. In: The UFAW Handbook on the Care and Management of Laboratory Animals, 5th ed. (UFAW, ed.), 173–192. London: Churchill Livingstone 1976.
Festing, M. F. W.: The Guinea-pig. In: The UFAW Handbook on the Care and Management of Laboratory Animals, 5th ed. (UFAW, ed.), 229–247. London: Churchill Livingstone 1976.
Huygelen, C., Peeterman, J.: Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals. Arch. ges. Virusforsch.21, 357–365 (1967).
Huygelen, C., Peetermans, J., Prinzie, A.: An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells. Progr. Med. Virol.11, 107–125 (1969).
Linnemann, C. C., Hutchinson, L., Rotte, T. C., Hegg, M. E., Schiff, G. M.: Stability of the rabbit immunogenic marker of RA 27/3 rubella vaccine virus after human passage. Infect. Immun.9, 547–549 (1974).
London, W. T., Fuccillo, D. A., Ley, A., Sever, J. L.: Antibody response of various strains of rubella virus when inoculated into rabbits. Proc. Soc. Exp. Biol. Med.137, 925–927 (1971).
Ministry of Health and Welfare, Japanese Government: Minimum Requirement of Biological Products. 1982.
Okabe, N.: Studies on rubella. III. Comparative studies in three rubella strains. An attenuated vaccine strain (TCRB-19), wild strains and a strain from congenital rubella syndrome. Journal of the Japanese Association for Infectious Disease54, 67–77 (1980). (In Japanese.)
Oxford, J. S., Potter, C. W.: An immunologic marker technique for the Cendehill vaccine strain of rubella virus. J. Immunol.111, 225–230 (1970).
Plotkin, S. A., Farquhar, J. D., Katz, M., Buser, F.: Attenuation of RA/3 rubella virus in WI-38 human diploid cells. Amer. J. Dis. Child.118, 178–185 (1969).
Preblud, S. R., Serdula, M. K., Frank, J. A., Brandling-Bennett, A. D., Hinmann, A. R.: Rubella vaccination in the United States: a ten-year review. Epidemiol. Rev.2, 171–194 (1980).
Shishido, A., Ohtawara, M.: Development of attenuated rubella virus vaccines in Japan. Jap. J. Med. Sci. Biol.29, 227–253 (1976).
W.H.O. Technical Report Series No. 610: Requirements for rubella vaccine (live) 1977.
Author information
Authors and Affiliations
Additional information
With 6 Figures
Rights and permissions
About this article
Cite this article
Ohtawara, M., Kobune, F., Umino, Y. et al. Inability of Japanese rubella vaccines to induce antibody response in rabbits is due to growth restriction at 39° C. Archives of Virology 83, 217–227 (1985). https://doi.org/10.1007/BF01309918
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309918